Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-12-048530)

Filing Details

Accession Number:: 0001140361-12-048530
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-11-21 17:13:38
Reporting Period:: 2012-11-06

Filing Date:: 2012-11-21
Accepted Time:: 2012-11-21 17:13:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
788920	Pro Dex Inc	PDEX	Surgical & Medical Instruments & Apparatus (3841)	841261240

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1478067	John Nicholas Swenson	3033 Excelsior Boulevard, Suite 560 Minneapolis MN 55416		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-11-06	53	$2.06	88,777	No	4	L	Indirect	By AO Partners I, LP
Common Stock	Acquisiton	2012-11-08	1,800	$2.00	90,577	No	4	L	Indirect	By AO Partners I, LP
Common Stock	Acquisiton	2012-11-13	50	$1.95	90,627	No	4	L	Indirect	By AO Partners I, LP
Common Stock	Acquisiton	2012-11-16	1,753	$1.98	92,380	No	4	L	Indirect	By AO Partners I, LP
Common Stock	Acquisiton	2012-11-19	9,884	$1.97	102,264	No	4	P	Indirect	By AO Partners I, LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	L	Indirect	By AO Partners I, LP
No	4	L	Indirect	By AO Partners I, LP
No	4	L	Indirect	By AO Partners I, LP
No	4	L	Indirect	By AO Partners I, LP
No	4	P	Indirect	By AO Partners I, LP

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	172,271	Indirect	By Glenhurst Co.
Common Stock	257,506	Direct

Footnotes

The price in Column 4 is a weighted average price. The prices actually paid ranged from $1.95 to $2.01. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.